Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOral - PhysicianPharm

Ga-68-FAPI for sarcoma imaging: Data from the FAPI-PET prospective observational trial

Lukas Kessler, Rainer Hamacher, Justin Ferdinandus, Fadi Zarrad, Nader Hirmas, Hans-Ulrich Schildhaus, Jens Siveke, Ken Herrmann and Wolfgang Fendler
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 126;
Lukas Kessler
1Nuclear medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen Essen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rainer Hamacher
2Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen Essen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin Ferdinandus
1Nuclear medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen Essen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fadi Zarrad
1Nuclear medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen Essen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nader Hirmas
1Nuclear medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen Essen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Ulrich Schildhaus
3Institute of Pathology, University Hospital Essen Essen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jens Siveke
5Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Hospital Essen Essen Germany
4Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site Essen) and German Cancer Research Center, DKFZ Heidelberg Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Herrmann
1Nuclear medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen Essen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Fendler
1Nuclear medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen Essen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 62 no. supplement 1 126

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 18, 2021.

Copyright & Usage 
© 2021

Author Information

  1. Lukas Kessler1,
  2. Rainer Hamacher2,
  3. Justin Ferdinandus1,
  4. Fadi Zarrad1,
  5. Nader Hirmas1,
  6. Hans-Ulrich Schildhaus3,
  7. Jens Siveke5,4,
  8. Ken Herrmann1 and
  9. Wolfgang Fendler1
  1. 1Nuclear medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen Essen Germany
  2. 2Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen Essen Germany
  3. 3Institute of Pathology, University Hospital Essen Essen Germany
  4. 4Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site Essen) and German Cancer Research Center, DKFZ Heidelberg Germany
  5. 5Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Hospital Essen Essen Germany

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2021 to April 2025

AbstractFullPdf
May 20213900
Jun 20217700
Jul 20217400
Aug 202110900
Sep 20214600
Oct 20218000
Nov 20215000
Dec 20213300
Jan 20226000
Feb 20224100
Mar 20222700
Apr 20224700
May 20222300
Jun 20223900
Jul 20222500
Aug 20221800
Sep 20223400
Oct 20221200
Nov 20221000
Dec 20221000
Jan 20231500
Feb 20231100
Mar 20231300
Apr 20231000
May 20231600
Jun 2023700
Jul 20231300
Aug 2023200
Sep 2023500
Oct 20231100
Nov 2023800
Dec 20231100
Jan 20241800
Feb 2024700
Mar 2024600
Apr 20242900
May 20241500
Jun 20243200
Jul 20246900
Aug 20246700
Sep 2024900
Oct 20241000
Nov 20241300
Dec 2024200
Jan 2025400
Feb 2025700
Mar 2025600
Apr 20251000
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ga-68-FAPI for sarcoma imaging: Data from the FAPI-PET prospective observational trial
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Ga-68-FAPI for sarcoma imaging: Data from the FAPI-PET prospective observational trial
Lukas Kessler, Rainer Hamacher, Justin Ferdinandus, Fadi Zarrad, Nader Hirmas, Hans-Ulrich Schildhaus, Jens Siveke, Ken Herrmann, Wolfgang Fendler
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 126;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Ga-68-FAPI for sarcoma imaging: Data from the FAPI-PET prospective observational trial
Lukas Kessler, Rainer Hamacher, Justin Ferdinandus, Fadi Zarrad, Nader Hirmas, Hans-Ulrich Schildhaus, Jens Siveke, Ken Herrmann, Wolfgang Fendler
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 126;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oral - PhysicianPharm

  • Optimization of 89Zr PET imaging using both phantom and clinical studies with [89Zr]-Df-IAB22M2C, an anti-CD8 minibody.
  • Progression and toxicity following liver Y90 radioembolization: impact of dose metrics, clinical factors, and biomarkers
  • Explainable prediction of all-cause mortality from myocardial PET flow and perfusion images using deep learning
Show more Oral - PhysicianPharm

Advances in PET Imaging for Cancer: Highlights of Clinical Diagnostics in Oncology

  • Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT
  • A Head-to-Head Comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/MR in Patients with Nasopharyngeal Carcinoma: A Prospective Study
Show more Advances in PET Imaging for Cancer: Highlights of Clinical Diagnostics in Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire